Catalent, Inc. is a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. The Company operates in three segments: Oral Technologies, Medication Delivery Solutions and Development & Clinical Services. Its oral, injectable, and respiratory delivery technologies address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. It is advanced delivery technology platforms, broad and deep intellectual property, and formulation, manufacturing and regulatory enable its customers to develop more products and better treatments. The Company provides a number of differentiated technologies, products and service offerings to its customers across a delivery technologies and development solutions platforms.